You are here: Industry Insights > vaccine

News List

Some Canadian Provinces Lift COVID Restrictions Amid Ongoing Protests drugs.com
February 10, 2022
Four Canadian provinces said this week that they'll lift their COVID-19 restrictions as the wave of cases caused by the Omicron variant has crested nationwide.
Seqirus Announces New Facility Supporting R&D of Leading-Edge Influenza Vaccine Technology AmericanPharmaceuticalReview
February 09, 2022
Seqirus, a business of CSL Limited, announced an investment in a new Research and Development (R&D) facility located in Waltham, Mass. The new facility will support the company's growing R&D portfolio...
Moderna to supply 10.8 million Covid-19 vaccine doses to Colombia Pharmaceutical-Technology
February 09, 2022
Initially, Moderna plans to supply one million doses of the vaccine in the first quarter of this year.
Sustainability vs single-use-tech: how COVID-19 has made biopharma more sustainable CPhIonline
February 09, 2022
COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.
Study finds COVID-19 less severe in fully vaccinated WorldPharmaNews
February 07, 2022
The clinical and imaging characteristics of COVID-19 breakthrough infections in fully vaccinated patients tend to be milder than those of partially vaccinated or unvaccinated patients...
Parental vaccination against coronavirus offers substantial protection to children as well WorldPharmaNews
February 07, 2022
The Clalit Research Institute, in collaboration with researchers from Harvard University and Tel-Aviv University, analyzed one of the world’s largest integrated health record databases to examine the indirect protection...
Gerresheimer Expands Injection Vials Production contractpharma
February 07, 2022
Investment increases production in Wertheim by 150 million vials and creates 70 new jobs.
Moderna starts trial for Omicron-specific booster shot ExpressPharma
January 29, 2022
The company said while a third shot of its original coronavirus vaccine increased neutralising antibodies against the variant at the lower dose, their levels declined six months after the booster dose was administered...
China's Walvax says has most participants for large mRNA COVID vaccine trial FirstWordPharma
January 28, 2022
An official at Walvax Biotechnology said the Chinese company has recruited most of the 28,000 participants needed for a large clinical trial of its mRNA COVID-19 vaccine candidate, as reported in Yahoo!News.
Delta variant, waning immunity reduced Pfizer vaccine's effectiveness against household transmission WorldPharmaNews
January 28, 2022
A new study by Yale School of Public Health (YSPH) researchers suggests that the Pfizer-BioNTech vaccine was more than 91% effective at reducing transmission of coronavirus in Israeli households before the emergence of the delta variant.